当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3747641
自主品牌
已选条件
-
T7305JQEZ5S-adenosyl,EZH2,JQEZ5,antitumor,methionine,JQEZ 5,H3K27me3,PRC2,inhibit,Inhibitor,JQEZ-5,Histon
JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM).
价 格：￥电议型 号：T7305产 地：中国大陆
-
T9700EZH2-IN-2EZH2IN2,EZH-2-IN-2,EZH2 IN 2
EZH2-IN-2 is a EZH2 inhibitor with an IC50 of 64 nM (Patent WO2018133795A1, Compound Example 69).
价 格：￥电议型 号：T9700产 地：中国大陆
-
T2079GSK126GSK2816126A；EZH2 inhibitor
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
价 格：￥电议型 号：T2079产 地：中国大陆
-
T2079GSK126GSK126,GSK2816126A,EZH2 inhibitor
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
价 格：￥电议型 号：T2079产 地：美洲
-
T6484EI1EI1,Ezh2 inhibitor,KB-145943
EI1 is a potent and selective EZH2 inhibitor with IC50 of 15 nM and 13 nM for EZH2 (WT) and EZH2 (Y641F), respectively.
价 格：￥电议型 号：T6484产 地：美洲
-
T79780IHMT-EZH2-426；化合物 IHMT-EZH2-426IHMT-EZH2-426
IHMT-EZH2-426 (compound 38) is a potent, covalent degrader of EZH2, demonstrating IC50 values of 1.3 nM for EZH2 wild-type, 1.2 nM for EZH2-A687V, and 1.7-3.5 nM for EZH2-Y641F/Y641N/Y641S mutants. The compound effectively inhibits proliferation in B-cell lymphoma and triple-negative breast cancer (TNBC) cell lines, attributed to its capacity to diminish H3K27me3 and EZH2 levels [1].
价 格：￥电议型 号：T79780产 地：中国大陆
-
T74602PROTAC EZH2 Degrader-1；化合物 PROTAC EZH2 Degrader-1PROTAC EZH2 Degrader-1
PROTAC EZH2 Degrader-1 (Compound 150d), a potent inhibitor, effectively suppresses EZH2 methyltransferase activity, demonstrating an IC50 of 2.7 nM. EZH2 is crucial in various tumorigenesis and development processes [1].
价 格：￥电议型 号：T74602产 地：中国大陆
-
T73246EZH2-IN-7；化合物 EZH2-IN-7EZH2-IN-7
EZH2-IN-7, a potent inhibitor of EZH2, addresses overexpression or mutations in the SET region (Y641F, Y641N, A687V, A677G point mutations) that cause an abnormal increase in H3K27me3, contributing to the proliferation of various tumors, including breast cancer, prostate cancer, and leukemia. It shows promise for cancer research applications.
价 格：￥电议型 号：T73246产 地：中国大陆
-
T73134EZH2-IN-14；化合物 EZH2-IN-14EZH2-IN-14
EZH2-IN-14 is a selective inhibitor of EZH2 (Histone Methyltransferase), demonstrating potent inhibition with an IC50 value of 12 nM. It specifically targets the methyltransferase activity of EZH2/PRC2, effectively reducing H3K27me3 levels. Moreover, EZH2-IN-14 exhibits more than 200-fold selectivity for EZH2 over the closely related H3K27 methyltransferase, EZH1.
价 格：￥电议型 号：T73134产 地：中国大陆
-
T67883EZH2-IN-15；化合物 EZH2-IN-15SHR2554；SHR2554
EZH2-IN-15 is a specific inhibitor of histone modifier enhancer of zeste 2 (EZH2). EZH2 is aberrantly overexpressed in a number of human cancers that controls the adaptive response via regulation of Treg activity. Intratumoral EZH2 expression has also been shown to control the innate immunity
价 格：￥电议型 号：T67883产 地：中国大陆
-
T6484EI1；化合物EI1KB-145943|||Ezh2 inhibitor；KB-145943|||Ezh2 inhibitor
EI1 (Ezh2 inhibitor) is a potent and selective EZH2 inhibitor with IC50 of 15 nM and 13 nM for EZH2 (WT) and EZH2 (Y641F), respectively.
价 格：￥电议型 号：T6484产 地：中国大陆
-
T64307EZH2-IN-8；化合物 EZH2-IN-8EZH2-IN-8
EZH2-IN-8 is a potent inhibitor of EZH2. EZH2-IN-8 has the potential to be used in the study of cancer diseases.
价 格：￥电议型 号：T64307产 地：中国大陆
-
T64208EZH2-IN-9；化合物 EZH2-IN-9EZH2-IN-9
EZH2-IN-9 is a potent inhibitor of EZH2, whose overexpression or mutations in the SET region (Y641F, Y641N, A687V, A677G point mutations) cause abnormal elevations in H3K27me3 and contribute to the growth and development of many tumours (e.g. breast cancer, prostate cancer, leukaemia, etc.). EZH2-IN-9 has shown potential for cancer research.
价 格：￥电议型 号：T64208产 地：中国大陆
-
T64043EZH2-IN-13；EZH2抑制剂3EZH2-IN-13
EZH2-IN-13 is a potent EZH2 inhibitor with potential anticancer activity.EZH2-IN-13 may be used to study diseases associated with EZH2 activity.
价 格：￥电议型 号：T64043产 地：中国大陆
-
T63970EZH2-IN-11；化合物 EZH2-IN-11EZH2-IN-11
EZH2-IN-11 is a potent inhibitor of E2HZ. The oncogenic activity of EZH2 has been demonstrated in numerous studies in a variety of different cancer types and EZH2-IN-11 has shown research potential for cancer diseases.
价 格：￥电议型 号：T63970产 地：中国大陆
-
T62896EZH2-IN-12；化合物 EZH2-IN-12EZH2-IN-12
EZH2-IN-12 (Compound 5) is a potent inhibitor of EZH2, which has potential for studies of CNS malignancies.
价 格：￥电议型 号：T62896产 地：中国大陆
-
T40323EZH2-IN-6EZH2-IN-6EZH2-IN-6
EZH2-IN-6 is an EZH2 inhibitor with enhanced antitumor activity.
价 格：￥电议型 号：T40323产 地：中国大陆
-
T40310PARP/EZH2-IN-1PARP/EZH2-IN-1PARP/EZH2-IN-1
PARP/EZH2-IN-1 is a novel compound that functions as a dual inhibitor for both PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for the treatment of triple-negative breast cancer with wild-type BRCA.
价 格：￥电议型 号：T40310产 地：中国大陆
-
T39497EZH2-IN-4EZH2-IN-4EZH2-IN-4
EZH2-IN-4 is a highly potent EZH2 inhibitor that can be taken orally. It exhibits inhibitory effects against wild type (WT) 5-membered (5-mer) EZH2 and mutant 5-mer EZH2, with IC 50 values of 0.923 nM and 2.65 nM, respectively. Moreover, EZH2-IN-4 has demonstrated significant anti-cancer activity.
价 格：￥电议型 号：T39497产 地：中国大陆
-
T38827EZH2-IN-5EZH2-IN-5EZH2-IN-5
EZH2-IN-5 is a highly effective inhibitor of EZH2, displaying remarkable potency against both wild-type and mutant Tyr641 EZH2, with IC50 values of 1.52 nM and 4.07 nM, respectively.
价 格：￥电议型 号：T38827产 地：中国大陆
